These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7795361)

  • 1. Two cases suggesting a role for the L-arginine nitric oxide pathway in neonatal blood pressure regulation.
    Fakler CR; Kaftan HA; Nelin LD
    Acta Paediatr; 1995 Apr; 84(4):460-2. PubMed ID: 7795361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats.
    Chen PY; Sanders PW
    Hypertension; 1993 Dec; 22(6):812-8. PubMed ID: 7503951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans.
    Haynes WG; Noon JP; Walker BR; Webb DJ
    J Hypertens; 1993 Dec; 11(12):1375-80. PubMed ID: 7510736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effects of acute amino acid infusion in hypertension induced by chronic nitric oxide blockade.
    Qiu C; Engels K; Samsell L; Baylis C
    Hypertension; 1995 Jan; 25(1):61-6. PubMed ID: 7843755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cardiovascular role of nitric oxide in conscious rats.
    Hu L; Manning RD; Brands MW
    Hypertension; 1994 Feb; 23(2):185-94. PubMed ID: 8307627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal-induced antihypertensive effect of vasopressin: role of the L-arginine/nitric oxide pathway.
    Talom RT; McNeill JR
    Can J Physiol Pharmacol; 1997 Jul; 75(7):812-7. PubMed ID: 9315348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo.
    Persson MG; Gustafsson LE; Wiklund NP; Moncada S; Hedqvist P
    Acta Physiol Scand; 1990 Dec; 140(4):449-57. PubMed ID: 1707210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric-oxide supplementation for treatment of long-term complications in argininosuccinic aciduria.
    Nagamani SC; Campeau PM; Shchelochkov OA; Premkumar MH; Guse K; Brunetti-Pierri N; Chen Y; Sun Q; Tang Y; Palmer D; Reddy AK; Li L; Slesnick TC; Feig DI; Caudle S; Harrison D; Salviati L; Marini JC; Bryan NS; Erez A; Lee B
    Am J Hum Genet; 2012 May; 90(5):836-46. PubMed ID: 22541557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats.
    Fernández N; García JL; García-Villalón AL; Monge L; Gómez B; Diéguez G
    Br J Pharmacol; 1993 Sep; 110(1):428-34. PubMed ID: 8220904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats.
    Gray GA; Schott C; Julou-Schaeffer G; Fleming I; Parratt JR; Stoclet JC
    Br J Pharmacol; 1991 May; 103(1):1218-24. PubMed ID: 1908734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nitric oxide in systemic and hepatic haemodynamics in the rat in vivo.
    Li X; Benjamin IS; Alexander B
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Aug; 368(2):142-9. PubMed ID: 12898126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Less nitric oxide, more pressure, or the converse?
    Umans JG
    Lancet; 1997 Mar; 349(9055):816-7. PubMed ID: 9121249
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway.
    Jin S; Teng X; Xiao L; Xue H; Guo Q; Duan X; Chen Y; Wu Y
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1831-1841. PubMed ID: 28971696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
    Miller AL
    Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-NAME, nitric oxide and jejunal motility, blood flow and oxygen uptake in dogs.
    Alemayehu A; Lock KR; Coatney RW; Chou CC
    Br J Pharmacol; 1994 Jan; 111(1):205-12. PubMed ID: 8012697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
    Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
    Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure.
    Alexander BT; Llinas MT; Kruckeberg WC; Granger JP
    Hypertension; 2004 Apr; 43(4):832-6. PubMed ID: 14769812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combined nitric oxide inhalation and NG-nitro-L-arginine infusion in porcine endotoxin shock.
    Weitzberg E; Rudehill A; Modin A; Lundberg JM
    Crit Care Med; 1995 May; 23(5):909-18. PubMed ID: 7736750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
    Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
    J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat.
    Morikawa E; Moskowitz MA; Huang Z; Yoshida T; Irikura K; Dalkara T
    Stroke; 1994 Feb; 25(2):429-35. PubMed ID: 7508154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.